biote Corp. (NASDAQ:BTMD - Get Free Report) major shareholder Guines Llc purchased 106,000 shares of the business's stock in a transaction dated Monday, March 31st. The stock was bought at an average cost of $3.32 per share, with a total value of $351,920.00. Following the completion of the acquisition, the insider now owns 4,033,547 shares of the company's stock, valued at approximately $13,391,376.04. The trade was a 2.70 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.
Guines Llc also recently made the following trade(s):
- On Monday, March 17th, Guines Llc acquired 100 shares of biote stock. The shares were bought at an average price of $3.74 per share, with a total value of $374.00.
- On Thursday, March 13th, Guines Llc bought 750,000 shares of biote stock. The stock was purchased at an average price of $3.22 per share, for a total transaction of $2,415,000.00.
biote Stock Performance
Shares of BTMD opened at $3.46 on Thursday. The company has a market capitalization of $189.30 million, a PE ratio of 13.31 and a beta of 1.07. biote Corp. has a fifty-two week low of $3.04 and a fifty-two week high of $8.44. The stock has a fifty day moving average of $4.44 and a two-hundred day moving average of $5.34.
Wall Street Analyst Weigh In
Separately, Craig Hallum lowered their price target on shares of biote from $12.00 to $8.00 and set a "buy" rating for the company in a report on Thursday, March 13th.
Get Our Latest Stock Report on biote
Institutional Trading of biote
A number of hedge funds have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD acquired a new position in biote during the fourth quarter worth approximately $67,000. Commonwealth Equity Services LLC purchased a new stake in biote during the fourth quarter valued at about $68,000. Public Employees Retirement System of Ohio purchased a new stake in biote during the fourth quarter valued at about $69,000. Intech Investment Management LLC acquired a new stake in biote during the fourth quarter worth about $71,000. Finally, SG Americas Securities LLC purchased a new position in shares of biote in the 4th quarter worth about $76,000. 21.68% of the stock is owned by institutional investors and hedge funds.
About biote
(
Get Free Report)
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
